Trevi Therapeutics, Inc. (TRVI) Social Stream
TREVI THERAPEUTICS INC (TRVI) Price Targets From Analysts
Use the tables below to see what analysts covering TREVI THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-13 | 2 | $10 | $10 | $10 | $2.44 | 309.84% |
| 2021-11-10 | 2 | $10 | $8 | $9 | $2.44 | 268.85% |
| 2022-01-13 | 1 | $8 | $8 | $8 | $2.44 | 227.87% |
| 2022-05-12 | 3 | $8 | $8 | $8 | $2.44 | 227.87% |
| 2022-05-25 | 4 | $10 | $8 | $8.666 | $2.44 | 255.16% |
| 2022-08-11 | 4 | $10 | $8 | $9.333 | $2.44 | 282.5% |
| 2022-10-02 | 4 | $12 | $8 | $10 | $2.44 | 309.84% |
| 2022-11-11 | 4 | $12 | $8 | $9.333 | $2.44 | 282.5% |
| 2022-11-14 | 5 | $9 | $8 | $8.333 | $2.44 | 241.52% |
| 2023-03-17 | 5 | $9 | $6 | $7.75 | $2.44 | 217.62% |
| 2023-05-14 | 5 | $9 | $6 | $7.4 | $2.44 | 203.28% |
The Trend in the Analyst Price Target
TRVI's average price target has moved down $1.6 over the prior 18 months.
TRVI reports an average of 278.24% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-01 | 4 | 10 | 8 | 9.333 | 2.92 | 219.62% |
| 2022-11-11 | 4 | 12 | 8 | 9.333 | 1.95 | 378.62% |
| 2023-01-03 | 5 | 9 | 6 | 7.750 | 2.03 | 281.77% |
| 2023-04-18 | 5 | 9 | 6 | 7.400 | 2.18 | 239.45% |
| 2023-05-12 | 5 | 9 | 6 | 7.400 | 2.83 | 161.48% |
TRVI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 4 | 1 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
TRVI's average broker recommendation rating improved by 0.47 over the prior 22 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TRVI as an investment opportunity.
- In the context of all US stocks, TREVI THERAPEUTICS INC's average analyst price target is greater than 132.71% of them.
- TREVI THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1319.91% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, TREVI THERAPEUTICS INC's number of analysts covering the stock is higher than 192.72% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, TREVI THERAPEUTICS INC's variance in analysts' estimates is lower than -73.78% of them.
In the Pharmaceutical Products industry, HOTH, TLSA, and RVPH are the three stocks most similar to TREVI THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding TRVI using the data that counts. Try POWR Ratings for free.